Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93
1 Centre National de Références Maladies Autoimmunes et systémiques rares Maladies Autoinflammatoires Rares et des Myopathies Inflammatoires, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 75013 Paris, France.
2 Cytometry and Biomarkers UTechS, Center for Translational Science, Institut Pasteur, Paris, France.
3 Sorbonne Université, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, CIC Pitié-Salpêtrière (CIC-1901), INSERM, Department of Pharmacology and Clinical Investigation Center, 75013 Paris, France.
4 Hôpital Pitié Salpêtrière-Charles Foix, AP-HP, Service de biochimie endocrinienne et oncologique, Paris, France; Sorbonne Université, Inserm, UMR_S 1166, Research Institute of Cardiovascular Disease, Metabolism and Nutrition, Paris, France.
5 Department of Biostatistics and Medical Information, AP-HP Saint-Louis University Hospital, ECSTRRA Team, CRESS UMR 1153, INSERM, University of Paris, Paris, France.
6 Centre National de Références Maladies Autoimmunes et systémiques rares Maladies Autoinflammatoires Rares et des Myopathies Inflammatoires, Sorbonne Universités, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 75013 Paris, France. Electronic address: [email protected].